Literature DB >> 11064381

Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.

C M Ofner1, Y E Zhang, V C Jobeck, B J Bowman.   

Abstract

Incomplete in vitro capsule shell dissolution and subsequent drug release problems have recently received attention. A modified USP dissolution method was used to follow capsule shell dissolution, and a 2,4,6-trinitrobenzenesulfonic acid (TNBS) assay was used to follow loss of epsilon-amino groups to study this shell dissolution problem postulated to be due to gelatin crosslinking. The dissolution problems were simulated using hard gelatin capsule (HGC) shells previously treated with formaldehyde to crosslink the gelatin. These methods were also used to study the effect of uncrosslinked HGC stored under stressed conditions (37 degrees C and 81% RH) with or without the presence of soft gelatin capsule shells (SGC). A 120 ppm formaldehyde treatment reduced gelatin shell dissolution to 8% within 45 min in water at 37 degrees C. A 200 ppm treatment reduced gelatin epsilon-amino groups to 83% of the original uncrosslinked value. The results also support earlier reports of non-amino group crosslinking by formaldehyde in gelatin. Under stressed conditions, HGC stored alone showed little change over 21 weeks. However, by 12 to 14 weeks, the HGC exposed to SGC showed a 23% decrease in shell dissolution and an 8% decrease in the number of epsilon-amino groups. These effects on the stressed HGC are ascribed to a volatile agent from SGC shells, most likely formaldehyde, that crosslinked nearby HGC shells. This report also includes a summary of the literature on agents that reduce gelatin and capsule shell dissolution and the possible mechanisms of this not-so-simple problem. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90: 79-88, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11064381     DOI: 10.1002/1520-6017(200101)90:1<79::aid-jps9>3.0.co;2-l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.

Authors:  Chialu Kevin Chang; Fernando A Alvarez-Nunez; Joseph V Rinella; Lars-Erik Magnusson; Katsuhiko Sueda
Journal:  AAPS PharmSciTech       Date:  2008-05-06       Impact factor: 3.246

2.  Adaptation of hard gelatin capsules for oral delivery of aqueous radiopharmaceuticals.

Authors:  Samia Mohamed Omar; Rania Safaa Abdel-Rashid; Mohamed Kamal AlAssaly; Tamer M Sakr
Journal:  Daru       Date:  2019-06-07       Impact factor: 3.117

3.  Pharmacokinetic Study of a Soft Gelatin Capsule and a Solid-Supersaturatable SMEDDS Tablet of Dutasteride in Beagle Dogs.

Authors:  Jeong-Soo Kim; Eun-Sol Ha; Heejun Park; Du Hyung Choi; Min-Soo Kim; In-Hwan Baek
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

4.  In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.

Authors:  Abdulmalik Alqurshi; K L Andrew Chan; Paul G Royall
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

5.  Innovative Water-Insoluble Edible Film Based on Biocatalytic Crosslink of Gelatin Rich in Glutamine.

Authors:  Yanli Ma; Ruijin Yang; Wei Zhao
Journal:  Foods       Date:  2020-04-16

6.  Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.

Authors:  Min-Soo Kim
Journal:  Int J Nanomedicine       Date:  2013-05-20

7.  Increasing mechanical strength of gelatin hydrogels by divalent metal ion removal.

Authors:  Qi Xing; Keegan Yates; Caleb Vogt; Zichen Qian; Megan C Frost; Feng Zhao
Journal:  Sci Rep       Date:  2014-04-16       Impact factor: 4.379

8.  Drying Behavior and Kinetics of Drying Process of Plant-Based Enteric Hard Capsules.

Authors:  Chuqi He; Haodong Wang; Yucheng Yang; Yayan Huang; Xueqin Zhang; Moses Arowo; Jing Ye; Na Zhang; Meitian Xiao
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.